1-3 of 3
Irene Raitman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development of CD19 CAR Engineered Human Placental CD34 + -Derived Natural Killer Cells (CAR19-CYNK) As an Allogeneic Cancer Immunotherapy

Marina Gergues, Irene Raitman, Joseph Gleason, Valentina Rousseva, Shuyang He, William Van Der Touw, Qian Ye, Lin Kang, Yanliang Zhang, Chin-I Pai, Wenzhong Guo, Henry Ji, Robert Hariri, Xiaokui Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2779.
https://doi.org/10.1182/blood-2021-150593
Published: 2021
Journal Articles

Human Placental CD34 + -Derived Natural Killer Cells with High Affinity and Cleavage Resistant CD16 (CYNK-101) in Combination with Daratumumab for Immunotherapy Against CD38 Expressing Hematological Malignancies

Irene Raitman, Joseph Gleason, Salvatore Rotondo, Shuyang He, Valentina Rousseva, Xuan Guo, Hemlata Rana, William van der Touw, Qian Ye, Lin Kang, Robert Hariri, Xiaokui Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2773.
https://doi.org/10.1182/blood-2021-148869
Published: 2021
Journal Articles

Human Placental CD34 + -Derived Natural Killer Cells with High Affinity and Cleavage Resistant CD16 (CYNK-101) for ADCC Mediated Cancer Immunotherapy

Lin Kang, Irene Raitman, PhD, Salvatore Rotondo, MS, Joseph Gleason, MS, Shuyang He, PhD, Srinivas Somanchi, PhD, Valentina Rousseva, MS, Xuan Guo, PhD, Hemlata Rana, MS, Andrea DiFiglia, BS, Qian Ye, PhD, Tanel Mahlakõiv, PhD, William Van Der Touw, Robert Hariri, MD PhD, Xiaokui Zhang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-140536
Published: 2020